Key result
Recruitment of MHCII hi LYVE1 lo CCR2 hi interstitial macrophages promotes medial fibrosis in pulmonary arterioles via the WNT11/PCP pathway, contributing to pulmonary hypertension severity.
Why the study?
Excessive pulmonary arteriole fibrosis and macrophage infiltration occur in pulmonary hypertension, but the potential associations between them remained obscure.
Does inhibition of MHCII hi LYVE1 lo CCR2 hi interstitial macrophage recruitment or pathogenicity reduce pulmonary arteriole medial fibrosis and pulmonary hypertension in experimental models?
Does inhibition of MHCII hi LYVE1 lo CCR2 hi interstitial macrophage recruitment or pathogenicity reduce pulmonary arteriole medial fibrosis and pulmonary hypertension in experimental models?
MHCII hi LYVE1 lo CCR2 hi interstitial macrophages drive pulmonary arteriole medial fibrosis in pulmonary hypertension via the WNT11/PCP pathway, presenting a potential novel therapeutic target.
Should not yet change PH practice; leaves open whether targeting CCR2hi iMΦs or WNT11 reverses human PA medial fibrosis.
BACKGROUND: Pulmonary hypertension (PH) is a lethal disease characterized in part by progressive pulmonary arteriole (PA) remodeling. Excessive PA fibrosis and macrophage infiltration are often present in PH, but the potential associations are obscure. We investigated the link between interstitial macrophage (iMΦ) infiltration and PA fibrosis in PH and idiopathic pulmonary arterial hypertension. METHODS: Lung tissue samples from patients with idiopathic pulmonary arterial hypertension and experimental PH animals were obtained to analyze the extent of fibrosis and iMΦ infiltration in the different layers of PAs and their correlation with disease severity. Single-cell RNA sequencing, lineage tracing, histological analyses, iMΦ and PA smooth muscle cell coculture, and transgenic animal experiments were used to investigate the cell heterogeneity and origins and molecular mechanisms by which iMΦs promote PA fibrosis. RESULTS: We found that increased collagen deposition and fibrosis in the PA media were most strongly related to the severity of PH, and medial iMΦ infiltration may be involved in these pathological processes. Single-cell transcriptomics revealed that major histocompatibility complex class II (high) lymphatic vessel endothelial hyaluronan receptor 1 (low) C-C motif chemokine receptor 2 (high) (MHCII hi LYVE1 lo CCR2 hi ) iMΦs were the major type of iMΦ that expanded upon Sugen-5416 and hypoxia plus normoxia stimulation and were responsible for PA medial fibrosis. Lineage tracing experiments suggested that these medial iMΦs were largely from recruited monocytes. Mechanistically, MHCII hi LYVE1 lo CCR2 hi iMΦs promoted the transition of PA smooth muscle cells to a fibroblast-like phenotype through the WNT11 (wingless member 11)/planar cell polarity (PCP) pathway. Wnt11 deletion in iMΦs from PH rats normalized the fibrotic PA smooth muscle cell phenotype and decreased PA medial fibrosis, thereby improving vascular compliance and protecting against PH. Moreover, myeloid-specific Ccr2 deficiency in PH-PAs inhibited the medial infiltration of MHCII hi LYVE1 lo CCR2 hi iMΦs, which also relieved PH. CONCLUSIONS: This study demonstrates that the recruitment of MHCII hi LYVE1 lo CCR2 hi iMΦs leads to medial fibrosis in PH-PAs associated with PH severity and that inhibition of their pathogenicity or recruitment reverses PA medial fibrosis and PH.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2025) studied Pulmonary hypertension. MHCII hi LYVE1 lo CCR2 hi interstitial macrophages was evaluated on Pulmonary arteriole medial fibrosis and pulmonary hypertension severity. Recruitment of MHCII hi LYVE1 lo CCR2 hi interstitial macrophages promotes medial fibrosis in pulmonary arterioles via the WNT11/PCP pathway, contributing to pulmonary hypertension severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: